Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025.

Arquivos brasileiros de cardiologia·2025
Same author

Rare genetic cerebrotendinous xanthomatosis (CTX) cases without cholestanol elevation but with prominent cholesterol-rich tendon xanthomas.

Journal of clinical lipidology·2024
Same author

Metabolic and Inflammatory Relationship between Covid-19 and Non-HDL-C.

Arquivos brasileiros de cardiologia·2023
Same author

Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023.

Arquivos brasileiros de cardiologia·2023
Same author

Endothelial Biomarkers and Translational Medicine: Still a Challenge.

Arquivos brasileiros de cardiologia·2022
Same author

Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021.

Arquivos brasileiros de cardiologia·2021

Related Experiment Video

Updated: Jun 13, 2026

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

[Left ventricular papillary fibroelastoma].

Renato Jorge Alves1, Alexandre H Borin, Carlos Renato De Oliveira

  • 1Hospital Santa Cruz, São Paulo, SP, Brasil. rjorge@cardiol.br

Arquivos Brasileiros De Cardiologia
|April 30, 2010
PubMed
Summary
This summary is machine-generated.

A rare case of Papillary Fibroelastoma (PFE) with upper limb embolization was treated. Percutaneous embolectomy and conservative management led to good outcomes without recurrence.

More Related Videos

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Related Experiment Videos

Last Updated: Jun 13, 2026

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Oncology

Background:

  • Papillary Fibroelastoma (PFE) is a rare cardiac tumor.
  • Embolization is a potential complication of cardiac tumors.

Observation:

  • A patient presented with PFE causing embolization to the upper right limb.
  • The patient underwent percutaneous embolectomy for fragment removal.

Findings:

  • Transthoracic echocardiogram and pathological analysis confirmed the PFE diagnosis.
  • The patient opted for conservative clinical treatment post-procedure.
  • Follow-up demonstrated good evolution with no disease recurrence.

Implications:

  • This case highlights the importance of considering PFE in embolic events.
  • Reviewing literature aids in determining optimal therapeutic strategies for rare cardiac tumors.
  • Conservative management can be effective in select PFE cases.